Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 9;13(8):1239.
doi: 10.3390/jpm13081239.

Copy Number Variations and Gene Mutations Identified by Multiplex Ligation-Dependent Probe Amplification in Romanian Chronic Lymphocytic Leukemia Patients

Beata Balla  1   2 , Florin Tripon  1   2 , Marcela Candea  3 , Claudia Banescu  1   2   4
Affiliations

Copy Number Variations and Gene Mutations Identified by Multiplex Ligation-Dependent Probe Amplification in Romanian Chronic Lymphocytic Leukemia Patients

Beata Balla et al. J Pers Med. .

Abstract

Chronic lymphocytic leukemia (CLL) is known for its wide-ranging clinical and genetic diversity. The study aimed to assess the associations between copy number variations (CNVs) and various biological and clinical features, as well as the survival rates of CLL patients and to evaluate the effectiveness of the multiplex ligation-dependent probe amplification (MLPA) technique in CLL patients.DNA was extracted from 110 patients, and MLPA was performed. Mutations in NOTCH1, SF3B1, and MYD88 were also analyzed. A total of 52 patients showed at least one CNV, 26 had at least one somatic mutation, and 10 presented both, CNVs, and somatic mutations. The most commonly identified CNVs were del(114.3), del(11q22.3), and dup(12q23.2). Other CNVs identified included del(17p13.1), del(14q32.33), dup(10q23.31), and del(19p13.2). One patient was identified with concomitant trisomy 12, 13, and 19. NOTCH1 and SF3B1 mutations were found in 13 patients each, either alone or in combination with other mutations or CNVs, while MYD88 mutation was identified in one patient. Forty-two patients had normal results. Associations between the investigated CNVs and gene mutations and patients' overall survival were found. The presence of NOTCH1 and SF3B1 mutations or the combination of NOTCH1 mutation and CNVs significantly influenced the survival of patients with CLL. Both mutations are frequently associated with different CNVs. Del(13q) is associated with the longest survival rate, while the shortest survival is found in patients with del(17p). Even if MLPA has constraints, it may be used as the primary routine analysis in patients with CLL.

Keywords: CLL; CNV; MLPA; MYD88; NOTCH1; SF3B1.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Study flowchart.
Figure 2
Figure 2
Survival of patients with CLL based on the genetic aberrations identified, presented in months. (a) Survival depending on the number of genetic aberrations; (b)survival depending on association of CNVs and somatic mutations;CLL—chronic lymphocytic leukemia; CNV—copy number variation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Shanafelt T.D., Geyer S.M., Kay N.E. Prognosis at Diagnosis: Integrating Molecular Biologic Insights into Clinical Practice for Patients with CLL. Blood. 2004;103:1202–1210. doi: 10.1182/blood-2003-07-2281. - DOI - PubMed
    1. Kipps T.J., Stevenson F.K., Wu C.J., Croce C.M., Packham G., Wierda W.G., O’Brien S., Gribben J., Rai K. Chronic Lymphocytic Leukaemia. Nat. Rev. Dis. Primer. 2017;3:16096. doi: 10.1038/nrdp.2016.96. - DOI - PMC - PubMed
    1. Campo E., Cymbalista F., Ghia P., Jäger U., Pospisilova S., Rosenquist R., Schuh A., Stilgenbauer S. TP53 Aberrations in Chronic Lymphocytic Leukemia: An Overview of the Clinical Implications of Improved Diagnostics. Haematologica. 2018;103:1956–1968. doi: 10.3324/haematol.2018.187583. - DOI - PMC - PubMed
    1. Puiggros A., Ramos-Campoy S., Kamaso J., de la Rosa M., Salido M., Melero C., Rodríguez-Rivera M., Bougeon S., Collado R., Gimeno E., et al. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL) Cancers. 2022;14:3376. doi: 10.3390/cancers14143376. - DOI - PMC - PubMed
    1. Stauder R., Eichhorst B., Hamaker M.E., Kaplanov K., Morrison V.A., Österborg A., Poddubnaya I., Woyach J.A., Shanafelt T., Smolej L., et al. Management of Chronic Lymphocytic Leukemia (CLL) in the Elderly: A Position Paper from an International Society of Geriatric Oncology (SIOG) Task Force. Ann. Oncol. 2017;28:218–227. doi: 10.1093/annonc/mdw547. - DOI - PubMed

LinkOut - more resources